~~<i id='3D8621B5EA'><strike id='3D8621B5EA'><tt id='3D8621B5EA'><pre id='3D8621B5EA'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：comprehensive 2025-10-01 14:48:06 Page View：24

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The untold story of TV’s first prescription drug ad
Next article： Peter Hotez and the public health issue of online harassment

explore

Peter Hotez and the public health issue of online harassment

AdobeFather’sDayweekendwasanythingbutcalmonTwitter,whicheruptedasvaccineexpertPeterHotezwaschallenge

AstraZeneca bets AAV gene therapy will still deliver the goods

AlastairGrant/APSengChenghasbeenworkingingenetherapyfornearlyaslongasgenetherapyhasbeenafield.Asayou

Alkermes shareholders re

MarkLennihan/APAlkermesshareholdersvotedThursdaytore-electallofthedrugmaker’scurrentdirectors,ending

Study finds new variant for Parkinson’s in African populations

AdobeAgroupofNigerian,British,andU.S.doctorshavediscoveredageneticvariantthatincreasestheriskofParki

WSS

Wikipedia

Wikipedia

knowledge

explore

Study finds new variant for Parkinson’s in African populations